Sovaldi: Who’s To Blame For The $1,000 A Day Price Tag?

By now, we’ve all heard of the Sovaldi Pricing controversy – Drug Pricing all over seem to be spiraling out of control! So why is Gilead taking so much heat over its $84,000 treatment plan? Read more here. (Source: Wharton University of Pennsylvania, 4/16/14).

You might also be interested in:

ICER Recommends Significant Reduction on Spinraza, Zolgensma… February 25, 2019
FDA OKs Jacobus Pharmaceuticals' LEMS Treatment May 13, 2019
Podcast Spotlights Small Change that Could Have Big Impact on… June 27, 2019
ICER Recommends Major Price Drop for Spinraza April 4, 2019
PAI and BresMed Join Forces to Support Expanded Use of More… July 22, 2019
Drug's $375K Price Tag Leads to Rationing, Criticism February 21, 2019
Survey: More Americans Blame Pharma for High Prices March 1, 2019